Brain spect imaging with99Tcm-hexamethylpropyleneamine oxime in the early detection of cerebral infarction: Comparison with transmission computed tomography

S. H. Yeh*, R. S. Liu, H. H. Hu, W. J. Wong, Y. K. Lo, Z. Y. Lai, J. C. Huang, S. L. Chang, S. J. Wang, F. L. Chu

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

28 Scopus citations

Abstract

A new cerebral blood flow agent,99Tcm-hexamethylpropyleneamine oxime (HM-PAO), was evaluated for early detection of acute cerebral infarction in conjunction with the transmission computed tomographic (CT) studies. The data from 22 cases were analysed. Results reveal that99Tcm-HM-PAO enables the early detection of acute cerebral infarction prior to CT with rather proper depiction of the extent of physiological abnormality in the majority of patients. This promising result together with the lack of logistical problems will make99Tcm-HM-PAO a useful and practical agent worldwide for diagnosing and managing acute cerebral infarction.

Original languageEnglish
Pages (from-to)873-878
Number of pages6
JournalNuclear Medicine Communications
Volume7
Issue number12
DOIs
StatePublished - Dec 1986

Fingerprint

Dive into the research topics of 'Brain spect imaging with99Tcm-hexamethylpropyleneamine oxime in the early detection of cerebral infarction: Comparison with transmission computed tomography'. Together they form a unique fingerprint.

Cite this